INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 285 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $754,472 | -19.3% | 14,484 | -1.9% | 0.00% | -60.0% |
Q2 2023 | $935,110 | +9.1% | 14,768 | -6.7% | 0.01% | +150.0% |
Q1 2023 | $856,924 | +22.7% | 15,825 | +19.9% | 0.00% | 0.0% |
Q4 2022 | $698,226 | +51.8% | 13,194 | +33.4% | 0.00% | +100.0% |
Q3 2022 | $460,000 | +83.3% | 9,888 | +124.6% | 0.00% | 0.0% |
Q2 2022 | $251,000 | -3.5% | 4,403 | +3.6% | 0.00% | 0.0% |
Q1 2022 | $260,000 | – | 4,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |